Enterprise League logo
Grid Therapeutics Logo

Grid Therapeutics

Durham, United States (US) · Health and Medical

Do your work at Grid Therapeutics?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

Overview

Grid Therapeutics is a Durham, North Carolina-based biotechnology company focused on developing targeted immunotherapy for cancer.

We are pioneering the first human-derived antibody, designated GT103, to treat refractory non-small cell lung cancer (NSCLC). Our approach leverages exceptional outcomes observed in early lung cancer patients, isolating and engineering a novel antibody from patient B-cells using advanced molecular genomic techniques.

Grid Therapeutics is currently enrolling patients in a Phase 1 clinical trial, representing a significant step forward in personalized cancer treatment. We are dedicated to advancing innovative solutions for patients battling difficult-to-treat cancers.

Founded in 2014, Grid Therapeutics builds upon the groundbreaking research of Edward F. Patz, Jr. MD and his team at Duke University Medical Center, bringing decades of scientific expertise to the development of life-saving therapies.

Most teams do this before shortlisting


Contact Details

info@gridtherapeutics.com

Durham, United States (US)

Founded

2014

Company Type

Private Limited Company

Employees

2-10

Keywords

You're invisible in searches for:

Add keywords that describe your company, services, or market to improve your visibility in search results.

Companies teams usually look at after Grid Therapeutics

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.